Ideal semaglutide candidates in Gallup have a BMI of 30 or more or a BMI of 27 or above with weight-related conditions like hypertension, type 2 diabetes, or high cholesterol
It's worth noting that Ozempic is licensed for type 2 diabetes, while Wegovy (also semaglutide, but at higher doses) is the UK-licensed product specifically for weight management
However, certain circumstances may warrant testing including pre-existing liver or kidney conditions where monitoring organ function during therapy provides appropriate oversight, specific health concerns that might benefit from objective biomarker assessment, desire to objectively measure oxidative stress markers or glutathione status before and during therapy, and medical conditions requiring monitoring for safety reasons
The relationship between diabetes and the menstrual cycle is a complex and multifaceted one
CV risk factors were prevalent: 71% had a history of hypertension, 60% had hyperlipidaemia, and 14% reported current smoking
Temperature management of the medication also influences injection comfort and tissue reaction